JAK2 and breast carcinoma: This could be explained by the activation of BAX mediated by the ABT‐737 previously described by Vaux et al37 Indeed, as already observed in breast cancer by Lin et al,38 BAX activation may down‐regulate upstream the JAK2 signal.